Nehal Chopra’s Kronos Bio KRON Stock Holding History

Nehal Chopra’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23,278	Closed	-$695K	–	153
2020 Q4	$695K	Buy	+23,278	New	+$730K	0.08%	94

Other funds holding KRON

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nehal Chopra's KRON Position: Q1 2021 in Review

Nehal Chopra sold out of Kronos Bio (KRON) in Q1 2021, closing a stake of 23,278 shares — an estimated $695K sold.

Nehal Chopra first reported a position in KRON in Q4 2020 and held it in 1 quarter. The position peaked at $695K in Q4 2020. 71 funds tracked by Wall St. Rank hold KRON as of Q1 2021.

Nehal Chopra reported no remaining Kronos Bio position as of Q1 2021 after selling out during the quarter.
Nehal Chopra sold 23,278 Kronos Bio shares in Q1 2021, an estimated $695K.
Nehal Chopra first reported a position in Kronos Bio in Q4 2020 and held it in 1 quarter.
Nehal Chopra's Kronos Bio position peaked at $695K in Q4 2020.
71 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2021.

Based on Ratan Capital Management's 13F filing for Q1 2021, filed 21 May 2021.